Suven Life Sciences secures product patents in Israel, Japan
Suven Life Sciences has secured one product patent from Israel and one product patent from Japan corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and patents are valid through 2036 and 2034 respectively. The granted claims of the patents include the class of selective M1 PAM and 5-HT4 … Read more